INTREPID TECHNOLOGY & RESOURCES, INC.
                          501 West Broadway, Suite 200
                            Idaho Falls, Idaho 83402
                                 (208) 529-5337


Mail Stop 0405


VIA FEDERAL EXPRESS AND EDGAR
- -----------------------------


April 15, 2005


Ms.  Mellissa  Duru
Division  of  Corporate  Finance
United  States  Securities  and  Exchange  Commission
450  Fifth  Street,  N.  W.,  Mail  Stop  0405
Washington,  D.C.  20549-0405

RE:  INTREPID TECHNOLOGY & RESOURCES, INC.
     FORM SB-2 FILED MARCH 11, 2005
     FILE NO. 333-123258


Dear  Ms.  Duru:

     Per  the  telephone  conversation  between  you and my attorney, Jacqueline
Hodes,  on April 13, 2005, Intrepid Technology & Resources, Inc. (the "Company")
                                                                       -------
has filed Amendment No. 1 to Form SB-2 Registration Statement on April 15, 2005,
which  incorporates  the  information  requested  by  the  Commission.

     Pursuant  to  the  Commission's  four  oral  comments,  we  have  taken the
following  steps:

     (1)  We have amended our Form 10-QSB for the period ended December 31, 2004
to  change the incorrect date included in our first amendment to the Form 10-QSB
for  that period.  Our amended Form 10-QSB now contains the correct Section 1350
certification  for  the  period  ending  December  31, 2004. In addition we have
refiled  all  required certifications, which are now dated as of the date of our
amended  Form  10-QSB.

     (2)  In  Amendment  No.1 to the Registration Statement, we have revised our
Selling  Stockholders  table to reflect the full amount and percentage of shares
currently  beneficially  owned  by  Cornell Capital Partners, LP, without taking
into  consideration  the 4.99% ownership limitation contained in the convertible
debentures.



Ms. Mellissa Duru
United States Securities and Exchange Commission
April 15, 2005
Page 2


     (3)  In  Amendment  No.  1  to  the Registration Statement, we have added a
table  which  demonstrates  the inverse relationship between our stock price and
the  number  of  shares  to  be issued to Cornell Capital Partners, LP under the
Standby  Equity  Distribution  Agreement at a recent stock price and at 25%, 50%
and  75%  discounts  to the recent price.  This table appears under the headings
"Offering" and "Standby Equity Distribution Agreement" in Amendment No. 1 to the
Registration  Statement.

     (4)  We  have  clarified  in  several  areas  in  Amendment  No.  1  to the
Registration  Statement  that the debentures issued to Cornell Capital Partners,
LP are convertible at the option of Cornell Capital Partners, LP and that if the
full  amount  of the convertible debentures or $750,000 is converted into shares
of  common stock of the Company, up to 13,636,364 shares of common stock will be
issued  to  Cornell  Capital Partners at any time up to the maturity date of the
convertible  debentures  (March  10,  2008).  However,  this  does not take into
consideration  the  4.99%  ownership limitation under the convertible debenture.
Further,  we  have clarified that the interest on the debentures may be payable,
at the sole option of Cornell Capital Partners, LP, in shares of common stock of
the  Company  or  in  cash  and  if Cornell Capital Partners, LP chooses to have
interest  be payable in common stock of the Company, as opposed to in cash, this
could have a dilutive impact on our stockholders and could cause our stock price
to  decline.  This  language regarding the dilutive impact of the debentures now
appears under the headings "Offering," "Risk Related To This Offering," "Selling
Stockholders"  and  "Liquidity  and  Capital  Resources."

     Enclosed  with  this letter is a redlined version of Amendment No. 1 to the
Registration Statement comparing it to the original registration statement filed
with  the  SEC  on  March  11,  2005.

     Please  call  me,  Jacqueline  Hodes at (305) 539-3387 or Clayton Parker at
(305)  539-3306  if  you  have  any  questions.


Very  truly  yours,




Dr. Dennis D. Keiser


                                      - 2 -